Quantification of the immunohistochemical staining of fibroblast activation protein in intrathoracic solitary fibrous tumors using QuPath

Purpose Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have been reports of SFTs being highly malignant. Fibroblast activation protein (FAP) is a serine protease, overexpressed in various cancers, whic...

Full description

Saved in:
Bibliographic Details
Published inSurgery today (Tokyo, Japan) Vol. 55; no. 9; pp. 1269 - 1273
Main Authors Omura, Akiisa, Kimura, Toru, Maniwa, Tomohiro, Watabe, Tadashi, Honma, Keiichiro, Shintani, Yasushi, Okami, Jiro
Format Journal Article
LanguageEnglish
Published Singapore Springer Nature Singapore 01.09.2025
Subjects
Online AccessGet full text
ISSN0941-1291
1436-2813
1436-2813
DOI10.1007/s00595-025-03024-y

Cover

Loading…
Abstract Purpose Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have been reports of SFTs being highly malignant. Fibroblast activation protein (FAP) is a serine protease, overexpressed in various cancers, which has been explored as a diagnostic and therapeutic target. We analyzed patients who underwent resection of an intrathoracic SFT, including metastatic pulmonary nodules from extrathoracic organs. Methods The subjects of this retrospective study were seven patients with a primary SFT and two with metastatic SFTs in the lungs. After immunohistochemical staining of the resected tumors, quantification of the stained area was performed using QuPath. Results Immunohistochemical quantification of FAP showed that it was expressed to varying degrees in the intrathoracic SFTs, with higher expression levels observed in metastatic SFTs than in primary pleural SFTs. Pathological examination confirmed the expression of FAP. Conclusion Our results support the potential usefulness of FAP in the diagnosis of intrathoracic SFTs, including metastatic pulmonary nodules.
AbstractList Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have been reports of SFTs being highly malignant. Fibroblast activation protein (FAP) is a serine protease, overexpressed in various cancers, which has been explored as a diagnostic and therapeutic target. We analyzed patients who underwent resection of an intrathoracic SFT, including metastatic pulmonary nodules from extrathoracic organs.PURPOSESolitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have been reports of SFTs being highly malignant. Fibroblast activation protein (FAP) is a serine protease, overexpressed in various cancers, which has been explored as a diagnostic and therapeutic target. We analyzed patients who underwent resection of an intrathoracic SFT, including metastatic pulmonary nodules from extrathoracic organs.The subjects of this retrospective study were seven patients with a primary SFT and two with metastatic SFTs in the lungs. After immunohistochemical staining of the resected tumors, quantification of the stained area was performed using QuPath.METHODSThe subjects of this retrospective study were seven patients with a primary SFT and two with metastatic SFTs in the lungs. After immunohistochemical staining of the resected tumors, quantification of the stained area was performed using QuPath.Immunohistochemical quantification of FAP showed that it was expressed to varying degrees in the intrathoracic SFTs, with higher expression levels observed in metastatic SFTs than in primary pleural SFTs. Pathological examination confirmed the expression of FAP.RESULTSImmunohistochemical quantification of FAP showed that it was expressed to varying degrees in the intrathoracic SFTs, with higher expression levels observed in metastatic SFTs than in primary pleural SFTs. Pathological examination confirmed the expression of FAP.Our results support the potential usefulness of FAP in the diagnosis of intrathoracic SFTs, including metastatic pulmonary nodules.CONCLUSIONOur results support the potential usefulness of FAP in the diagnosis of intrathoracic SFTs, including metastatic pulmonary nodules.
Purpose Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have been reports of SFTs being highly malignant. Fibroblast activation protein (FAP) is a serine protease, overexpressed in various cancers, which has been explored as a diagnostic and therapeutic target. We analyzed patients who underwent resection of an intrathoracic SFT, including metastatic pulmonary nodules from extrathoracic organs. Methods The subjects of this retrospective study were seven patients with a primary SFT and two with metastatic SFTs in the lungs. After immunohistochemical staining of the resected tumors, quantification of the stained area was performed using QuPath. Results Immunohistochemical quantification of FAP showed that it was expressed to varying degrees in the intrathoracic SFTs, with higher expression levels observed in metastatic SFTs than in primary pleural SFTs. Pathological examination confirmed the expression of FAP. Conclusion Our results support the potential usefulness of FAP in the diagnosis of intrathoracic SFTs, including metastatic pulmonary nodules.
Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have been reports of SFTs being highly malignant. Fibroblast activation protein (FAP) is a serine protease, overexpressed in various cancers, which has been explored as a diagnostic and therapeutic target. We analyzed patients who underwent resection of an intrathoracic SFT, including metastatic pulmonary nodules from extrathoracic organs. The subjects of this retrospective study were seven patients with a primary SFT and two with metastatic SFTs in the lungs. After immunohistochemical staining of the resected tumors, quantification of the stained area was performed using QuPath. Immunohistochemical quantification of FAP showed that it was expressed to varying degrees in the intrathoracic SFTs, with higher expression levels observed in metastatic SFTs than in primary pleural SFTs. Pathological examination confirmed the expression of FAP. Our results support the potential usefulness of FAP in the diagnosis of intrathoracic SFTs, including metastatic pulmonary nodules.
Author Kimura, Toru
Maniwa, Tomohiro
Shintani, Yasushi
Watabe, Tadashi
Honma, Keiichiro
Omura, Akiisa
Okami, Jiro
Author_xml – sequence: 1
  givenname: Akiisa
  surname: Omura
  fullname: Omura, Akiisa
  organization: Department of General Thoracic Surgery, Osaka International Cancer Institute, Department of General Thoracic Surgery, Osaka University Graduate School of Medicine
– sequence: 2
  givenname: Toru
  surname: Kimura
  fullname: Kimura, Toru
  email: kimura@thoracic.med.osaka-u.ac.jp
  organization: Department of General Thoracic Surgery, Osaka International Cancer Institute, Department of General Thoracic Surgery, Osaka University Graduate School of Medicine
– sequence: 3
  givenname: Tomohiro
  surname: Maniwa
  fullname: Maniwa, Tomohiro
  organization: Department of General Thoracic Surgery, Osaka International Cancer Institute
– sequence: 4
  givenname: Tadashi
  surname: Watabe
  fullname: Watabe, Tadashi
  organization: Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine
– sequence: 5
  givenname: Keiichiro
  surname: Honma
  fullname: Honma, Keiichiro
  organization: Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute
– sequence: 6
  givenname: Yasushi
  surname: Shintani
  fullname: Shintani, Yasushi
  organization: Department of General Thoracic Surgery, Osaka University Graduate School of Medicine
– sequence: 7
  givenname: Jiro
  surname: Okami
  fullname: Okami, Jiro
  organization: Department of General Thoracic Surgery, Osaka International Cancer Institute
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40126602$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1q3DAUhUVJaSZpX6CLomU3bq_-bHlVSugfBNJAshayRhor2NJUkgPzCH3rauI0tJuAhBb3O-feq3OGTkIMFqG3BD4QgO5jBhC9aIDWy4Dy5vACbQhnbUMlYSdoAz0nDaE9OUVnOd9BZSTAK3TKgdC2BbpBv68XHYp33ujiY8DR4TJa7Od5CXH0uUQz2rlWJ5yL9sGH3ZFxfkhxmHQuWJvi71fxPsVifcAPpyRdxpi08QbnOPmi02HVLRmXZY4p4yUf_a6XnxV9jV46PWX75vE9R7dfv9xcfG8ur779uPh82RjOeWkItI51tBVgBKVSs9bJlg2d6G0HxDHJad8J1zEQneNdO2xFP2wHZzTrhWwJO0efVt_9Msx2a-xx0kntk5_rhCpqr_6vBD-qXbxXhDIJfQ_V4f2jQ4q_FpuLmn02dpp0sHU5xUjlJCeSVfTdv82euvwNoAJ0BUyKOSfrnhAC6piyWlNWNWX1kLI6VBFbRbnCYWeTuotLCvXXnlP9ATRtrmc
Cites_doi 10.2967/jnumed.123.266393
10.1007/s00259-022-06052-9
10.1186/s13019-023-02168-7
10.1002/prca.201300095
10.2967/jnumed.123.266411
10.1097/JTO.0b013e3182653d64
10.1038/modpathol.2013.164
10.2967/jnumed.123.265481
10.1016/j.cpet.2023.02.007
10.1016/j.urology.2019.01.029
10.1007/s00330-023-10013-7
10.3892/ol.2022.13375
10.1158/1078-0432.CCR-19-2238
10.1186/s13000-021-01095-2
10.2967/jnumed.123.265486
10.3390/ijms24032746
10.1016/S0003-4975(01)03374-4
10.1016/j.prp.2024.155380
10.2967/jnumed.122.264544
10.1016/j.annonc.2024.08.712
10.1038/s41598-017-17204-5
10.1097/RLU.0000000000003598
10.1155/2023/2480493
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1007/s00595-025-03024-y
DatabaseName SpringerOpen
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen Free (Free internet resource, activated by CARLI)
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1436-2813
EndPage 1273
ExternalDocumentID PMC12380990
40126602
10_1007_s00595_025_03024_y
Genre Journal Article
GrantInformation_xml – fundername: Japan Society for the Promotion of Science
  grantid: JP22K09014
  funderid: http://dx.doi.org/10.13039/501100001691
– fundername: Osaka University
– fundername: Japan Society for the Promotion of Science
  grantid: JP22K09014
GroupedDBID ---
-Y2
-~C
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
123
1SB
2.D
203
28-
29Q
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2WC
2~H
30V
3O-
4.4
406
408
409
40D
40E
53G
5QI
5VS
67Z
6NX
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABRTQ
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHVE
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACSTC
ACUDM
ACZOJ
ADHHG
ADHIR
ADHKG
ADIMF
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFEXP
AFHIU
AFLOW
AFOHR
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHPBZ
AHSBF
AHWEU
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
ATHPR
AXYYD
AYFIA
AZFZN
B-.
BA0
BBWZM
BDATZ
BGNMA
BSONS
C6C
CAG
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M4Y
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P9S
PF0
PT4
PT5
QOK
QOR
QOS
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
X7M
YLTOR
Z45
ZMTXR
ZOVNA
~A9
~EX
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c444t-106f372650c5228a36f863b759e701f3842975f73057f476bd59bdbfca3958613
IEDL.DBID U2A
ISSN 0941-1291
1436-2813
IngestDate Fri Aug 29 05:29:37 EDT 2025
Fri Sep 05 06:10:53 EDT 2025
Wed Sep 03 02:27:45 EDT 2025
Wed Aug 27 16:41:28 EDT 2025
Wed Aug 27 01:34:09 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Pleural tumor
Malignant potential
Solitary fibrous tumor
Fibroblast activation protein
Diagnostic target
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c444t-106f372650c5228a36f863b759e701f3842975f73057f476bd59bdbfca3958613
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://link.springer.com/10.1007/s00595-025-03024-y
PMID 40126602
PQID 3180984183
PQPubID 23479
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_12380990
proquest_miscellaneous_3180984183
pubmed_primary_40126602
crossref_primary_10_1007_s00595_025_03024_y
springer_journals_10_1007_s00595_025_03024_y
PublicationCentury 2000
PublicationDate 20250900
PublicationDateYYYYMMDD 2025-09-01
PublicationDate_xml – month: 9
  year: 2025
  text: 20250900
PublicationDecade 2020
PublicationPlace Singapore
PublicationPlace_xml – name: Singapore
– name: Japan
PublicationSubtitle Official Journal of the Japan Surgical Society
PublicationTitle Surgery today (Tokyo, Japan)
PublicationTitleAbbrev Surg Today
PublicationTitleAlternate Surg Today
PublicationYear 2025
Publisher Springer Nature Singapore
Publisher_xml – name: Springer Nature Singapore
References T Watabe (3024_CR5) 2023; 64
M de Perrot (3024_CR14) 2002; 74
H Ajouz (3024_CR17) 2023; 18
T Kimura (3024_CR11) 2024; 259
F Lococo (3024_CR15) 2012; 7
F Lococo (3024_CR16) 2014; 33
P Rasinski (3024_CR23) 2023; 64
Q Zheng (3024_CR13) 2023; 24
LA Doyle (3024_CR19) 2014; 27
Q Yang (3024_CR24) 2024; 34
A Zhang (3024_CR25) 2021; 46
CJ Twelves (3024_CR9) 2024; 35
R Hamacher (3024_CR10) 2024; 65
Y Pang (3024_CR22) 2023; 64
S Sammoud (3024_CR3) 2019; 127
M Fabre (3024_CR8) 2020; 26
P Bankhead (3024_CR12) 2017; 7
Q Li (3024_CR2) 2022; 24
Y Mori (3024_CR7) 2023; 18
W Li (3024_CR21) 2023; 13
MU Tariq (3024_CR1) 2021; 16
JN Crane (3024_CR18) 2023; 2023
AF van den Hoven (3024_CR6) 2023; 50
AM Spektor (3024_CR20) 2024; 65
EJ Hamson (3024_CR4) 2014; 8
References_xml – volume: 65
  start-page: 52
  year: 2024
  ident: 3024_CR20
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.123.266393
– volume: 50
  start-page: 1014
  year: 2023
  ident: 3024_CR6
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-022-06052-9
– volume: 18
  start-page: 79
  year: 2023
  ident: 3024_CR17
  publication-title: J Cardiothorac Surg
  doi: 10.1186/s13019-023-02168-7
– volume: 8
  start-page: 454
  year: 2014
  ident: 3024_CR4
  publication-title: Proteomics Clin Appl
  doi: 10.1002/prca.201300095
– volume: 65
  start-page: 252
  year: 2024
  ident: 3024_CR10
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.123.266411
– volume: 7
  start-page: 1698
  year: 2012
  ident: 3024_CR15
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e3182653d64
– volume: 27
  start-page: 390
  year: 2014
  ident: 3024_CR19
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2013.164
– volume: 64
  start-page: 1232
  year: 2023
  ident: 3024_CR23
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.123.265481
– volume: 18
  start-page: 419
  year: 2023
  ident: 3024_CR7
  publication-title: PET Clin
  doi: 10.1016/j.cpet.2023.02.007
– volume: 127
  start-page: 9
  year: 2019
  ident: 3024_CR3
  publication-title: Urology
  doi: 10.1016/j.urology.2019.01.029
– volume: 34
  start-page: 1077
  year: 2024
  ident: 3024_CR24
  publication-title: Eur Radiol
  doi: 10.1007/s00330-023-10013-7
– volume: 24
  start-page: 255
  issue: 2
  year: 2022
  ident: 3024_CR2
  publication-title: Oncol Lett
  doi: 10.3892/ol.2022.13375
– volume: 26
  start-page: 3420
  year: 2020
  ident: 3024_CR8
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-19-2238
– volume: 16
  start-page: 32
  year: 2021
  ident: 3024_CR1
  publication-title: Diagn Pathol
  doi: 10.1186/s13000-021-01095-2
– volume: 13
  start-page: 4547
  year: 2023
  ident: 3024_CR21
  publication-title: Am J Cancer Res
– volume: 33
  start-page: 109
  year: 2014
  ident: 3024_CR16
  publication-title: Rev Esp Med Nucl Imagen Mol
– volume: 64
  start-page: 1225
  year: 2023
  ident: 3024_CR5
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.123.265486
– volume: 24
  start-page: 2746
  year: 2023
  ident: 3024_CR13
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms24032746
– volume: 74
  start-page: 285
  year: 2002
  ident: 3024_CR14
  publication-title: Ann Thorac Surg
  doi: 10.1016/S0003-4975(01)03374-4
– volume: 259
  year: 2024
  ident: 3024_CR11
  publication-title: Pathol Res Pract
  doi: 10.1016/j.prp.2024.155380
– volume: 64
  start-page: 386
  year: 2023
  ident: 3024_CR22
  publication-title: Prospective Study J Nucl Med
  doi: 10.2967/jnumed.122.264544
– volume: 35
  start-page: S511
  year: 2024
  ident: 3024_CR9
  publication-title: Ann Oncol
  doi: 10.1016/j.annonc.2024.08.712
– volume: 7
  start-page: 16878
  year: 2017
  ident: 3024_CR12
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-17204-5
– volume: 46
  start-page: e534
  year: 2021
  ident: 3024_CR25
  publication-title: Clin Nucl Med
  doi: 10.1097/RLU.0000000000003598
– volume: 2023
  start-page: 2480493
  year: 2023
  ident: 3024_CR18
  publication-title: Sarcoma
  doi: 10.1155/2023/2480493
SSID ssj0024800
Score 2.4048834
Snippet Purpose Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have...
Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that can develop in the pleura. In the past, SFTs were considered benign, but there have been...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1269
SubjectTerms Adult
Aged
Biomarkers, Tumor - analysis
Biomarkers, Tumor - metabolism
Endopeptidases
Female
Gelatinases - analysis
Gelatinases - metabolism
Humans
Immunohistochemistry - methods
Lung Neoplasms - diagnosis
Lung Neoplasms - secondary
Male
Medicine
Medicine & Public Health
Membrane Proteins - analysis
Membrane Proteins - metabolism
Middle Aged
Original
Original Article
Retrospective Studies
Serine Endopeptidases - analysis
Serine Endopeptidases - metabolism
Solitary Fibrous Tumors - diagnosis
Solitary Fibrous Tumors - metabolism
Solitary Fibrous Tumors - pathology
Solitary Fibrous Tumors - surgery
Surgery
Surgical Oncology
Thoracic Neoplasms - diagnosis
Thoracic Neoplasms - pathology
Title Quantification of the immunohistochemical staining of fibroblast activation protein in intrathoracic solitary fibrous tumors using QuPath
URI https://link.springer.com/article/10.1007/s00595-025-03024-y
https://www.ncbi.nlm.nih.gov/pubmed/40126602
https://www.proquest.com/docview/3180984183
https://pubmed.ncbi.nlm.nih.gov/PMC12380990
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1da9swFL2sLYy9jH118z6CBntrDYklWfJjGpqVjZUVGmifjKRYbR5qj9h-yE_Yv969sp2RtRQGNn6w7Ng-su5R7j3HAF-EUkZJm8VLwV0sPL1SGJniSebGQhWcDFuo2uI8PVuIb1fyqheF1UO1-5CSDCP1VuxGOklSE-PKMbLEmz04kDh3p0K-RTL967CnO-FJJiYxRrNJL5V5-By74egex7xfKvlPvjSEofkLeN7zRzbtAH8JT4ryFTz90WfIX8Pvi9Z09T_hkbPKM6R4bEUykCqYC7veIoAF5RT-CLXxOGuuLDLphpHSofuflgUTh1XJwkI2trfYYdzKsZqq5sx60x3X1qxp76p1zaiK_oZdtD-x6RtYzE8vZ2dx_7mF2AkhGhyQU89VgpTNISnThqdep9wqmRVqPEEUBalwPQ4JUnmhUruUmV1a7wzPpEZacAj7ZVUW74B5hdAn1nFlcP5pkkw7La3x0ogsUdJFcDQ89fxX56qRb_2TA0Y5YpQHjPJNBJ8HYHLs_JTRMGWBN5dzch_TAoelCN52QG3PhxNHJB_jJAK9A-G2ARlr7-4pV7fBYBujuaaEYQTHA9p5_2rXj1zn-_9r_gGeJaEnUsHaR9hv1m3xCRlOY0dwMJ2fnJzT9uv199MR7M3S2Sh08z9nU_no
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwEB3BVoJeCgXapnzUSNwg1W5sx86xQi0L_RCVulI5WbY3pivUpNokh-Uf8K87dpJF2yKkSskpTrK2xzPPO_NeAD4wIbTgJounjNqYOb-kMDLFo8wOmcipF2zx1RZn6XjCvl3yy44UVvXV7n1KMnjqJdnN8yQ9mxhPipElXjyGNYZ7cDaAtYMvP44P_2rsyZZ6krFRjPFs1JFl_v2U1YB0D2XeL5a8kzENgejoGUz6LrT1J7_2m9rs29931B0f2sfnsNEhU3LQmtImPMqLF_DktMu9v4Q_541uK4vCZJLSEQSPZOYJJmWQLbad-AAJnCx8r2_jcD9eGsToNfEcivYfYBLkIWYFCYcXyL1CU7QzSypfj6fni_a-piJ1c13OK-Lr83-S8-Y7Nn0Fk6PDi8_juPuQQ2wZYzW6-tRRkSAYtAj3pKapkyk1gme5GI7QPpjn9zp0Nlw4JlIz5ZmZGmc1zbhEwLEFg6Is8h0gTqBRJcZSoXFnq5NMWsmNdlyzLBHcRvCxn0110-p1qKUycxhdhaOrwuiqRQTv-wlXuKx8rkQXOXZOUa9rJhk6vAi2WwNYPg-3pAhrhkkEcsU0lg28ZPfqlWJ2FaS7ESdIn4qM4FNvAKpzGtV_fufuw5rvwdPxxemJOvl6dvwa1pNgT74s7g0M6nmTv0UcVZt33bK5BQ1WFjE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BVqq4lDcNTyNxg7S7iR07x6rtUihUrUSlcopsb0xXVZNqNzks_4B_zYydLGyLkBBScopj-TH2fM7M9wXgDZdSS2HyeMJTG3NHSwo9UzzK7ZDLMiXBFsq2OMoOTvnHM3H2G4vfZ7v3IcnAaSCVpqrZvpq47SXxjTiTxCzGO0UvEy9uwxoncfYBrO28_3q4_0tvTwUaSs5HMfq2UUec-XMtq87pBuK8mTh5LXrqndL4Lui-OyEX5WKrbcyW_X5N6fF_-nsPNjrEynaCid2HW2X1ANY_dzH5h_DjpNUh48hPMqsdQ1DJpkQ8qb2cse1ECZjnamEbqIzDc3ptELs3jLgV4csw87IR04r5i4Rzz9FE7dSyOeXp6dkivNfOWdNe1rM5o7z9b-ykPcaij-B0vP9l9yDufvAQW855gy4gc6lMECRahIFKp5lTWWqkyEs5HKHdcOL9OtyEhHRcZmYicjMxzuo0FwqByGMYVHVVbgJzEo0tMTaVGk-8OsmVVcJoJzTPEylsBG_7mS2ugo5HsVRs9qNb4OgWfnSLRQSv-8kvcLlRDEVXJXauSEnvTHHcCCN4EoxhWR8eVRHuDJMI1IqZLAuQlPfqk2p67iW9ET8oClFG8K43hqLbTOZ_aefTfyv-CtaP98bFpw9Hh8_gTuLNibLlnsOgmbXlC4RXjXnZraCfXWofFQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantification+of+the+immunohistochemical+staining+of+fibroblast+activation+protein+in+intrathoracic+solitary+fibrous+tumors+using+QuPath&rft.jtitle=Surgery+today+%28Tokyo%2C+Japan%29&rft.au=Omura%2C+Akiisa&rft.au=Kimura%2C+Toru&rft.au=Maniwa%2C+Tomohiro&rft.au=Watabe%2C+Tadashi&rft.date=2025-09-01&rft.eissn=1436-2813&rft.volume=55&rft.issue=9&rft.spage=1269&rft_id=info:doi/10.1007%2Fs00595-025-03024-y&rft_id=info%3Apmid%2F40126602&rft.externalDocID=40126602
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0941-1291&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0941-1291&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0941-1291&client=summon